Electrophysiology Devices Market: Growth Drivers, Opportunity, Key Players, And Regional Analysis

By Author: Strategic Market Research
Total Articles: 19
Comment this article

Healthcare professionals worldwide are improving their ability to diagnose & treat patients with the help of electrophysiology devices. Hospitals, cardiac centers, and laboratories may have access to electrophysiology equipment such as ablation catheters, a radiofrequency generator, a 3D mapping system, and access electrophysiology devices. Cardiac ablation is one of the most frequently used treatments for atrial fibrillation.

In 2021, the market for electrophysiology devices was worth USD 6.2 billion, and by 2030, it will be worth USD 15.60 billion, growing at a 10.8% CAGR during the forecast period. 

The market for electrophysiology devices is driven by factors like expanding geriatric population, the rising rate of arrhythmia, and the rising popularity of catheter ablation procedures. The development of the electrophysiology devices market is being hampered by negative healthcare reforms in some areas and a s

Market Dynamics

Drivers

The demand for catheter ablation procedures, rising arrhythmia occurrences, and the extensive usage of cardiovascular surgery in emerging countries contribute ...
... to the growth of the electrophysiology devices market. The growing prevalence of heart failure and cardiac failure cases among adolescents due to lifestyle variables, including smoking and alcohol use, are additional major growth drivers for the electrophysiology devices industry.

The market for electrophysiology devices will benefit significantly from technological developments such as lipid bilayer recording, implantable cardioverter defibrillators, trans epithelial recording, voltage-clamp recording, current-clamp recording, and calculating impedance measurements.

Restraints

The development of the electrophysiology devices market is being hampered by a shortage of qualified and experienced electrophysiologists in developing countries and negative healthcare policies in some areas.

Opportunity 

Vendors of electrophysiology will experience significant growth prospects in emerging regions. This results from factors such as a rise in the patient population, rising disposable incomes, better healthcare infrastructure, and more lenient regulations than in industrialized nations. 

Market Segmentation

By Application 

The diagnostic devices category held the biggest share of 52.1% CAGR in 2022. The largest share is due to the widespread use of cardiac monitors as a diagnostic and monitoring tool for arrhythmias and the high adoption rates of ambulatory monitoring equipment. During the forecast period, segment growth will be driven by the expanding usage of these devices in interventional medical procedures, like catheter placement, and the development of portable & digital systems.

By Indication

In 2022, the atrial fibrillation segment led the market with a share of more than 32.3%. It is the most prevalent arrhythmia and is related to a high risk of blood clotting and stroke. In 2022, the British Heart Association predicts that 1.5 million people in the UK have atrial fibrillation. In addition, the nation's undetected atrial fibrillation affects an estimated 270,000 people 65 and older. The disease's high prevalence causes a significant portion of the section.

By End-Use

In 2022, the hospitals were the market leader, with 54.1% of the revenue share. It is because of the rising use of innovative cardiac rhythm management & EP technologies and the growing prevalence of cardiovascular disease (CVD). The ASCs segment is anticipated to develop significantly, with a CAGR of 11.81%.

Regional Analysis 

North America was the major market contributor, with the largest share of over 37.5% in 2021. This significant revenue share is due to the high prevalence of cardiovascular diseases, swift adoption of modern treatment and diagnostic technologies, increased research activities, and the presence of major market players. Furthermore, large investments and finances in cardiovascular illnesses and the constant release of breakthrough technologies drive the revenue expansion of North America. 

Europe was the second-largest market. This significant revenue expansion can be attributed to the widespread use of novel treatment methods/techniques and improved healthcare infrastructure.

Asia Pacific is an emerging region in terms of revenue share due to factors such as improving healthcare infrastructure, increasing cardiovascular disease prevalence, and the availability of favorable reimbursement policies. Furthermore, the rise of medical tourism and the increasing use of new technologies for improved outcomes and better survival rates exponentially increase regional revenue.

Key players 

Biotronik SE & Co. KG
Abbott Laboratories
Boston Scientific Corporation
GE electrophysiology (Healthcare)
CardioFocus, Inc.
Koninklijke Philips N.V.
Medtronic Plc.
Johnson & Johnson, Inc.
MicroPort Scientific Corporation
AtriCure, Inc.
Siemens Healthineers AG
Biosense Webster
Stereotaxis, Inc.
AngioDynamics

In 2021, the market for electrophysiology devices was worth USD 6.2 billion, and by 2030, it will be worth USD 15.60 billion, growing at a 10.8% CAGR during the forecast period. The market for electrophysiological devices is stimulated by factors such as the rising older population, the rising number of cardiovascular patients, and the expanding disease awareness initiatives in many emerging nations.

Related Reports:
Industrial Air Compressor Market Report - The global industrial air compressor market will witness a robust CAGR of 3.9%, valued at $32.42 billion in 2021, expected to appreciate and reach $43.75 billion by 2030, confirms Strategic Market Research.